<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>药明康德 | wechat-feeds</title><link>http://MzAwMDA5NTIxNQ.favicon.privacyhide.com/favicon.ico</link><description>全球领先的制药、生物技术以及医疗器械研发开放式能力和技术平台，帮助任何人、任何公司更快、更好地研发新医药产品，探索无限可能</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 05 Mar 2021 11:33:22 +0800</pubDate><image><url>http://MzAwMDA5NTIxNQ.favicon.privacyhide.com/favicon.ico</url><title>药明康德 | wechat-feeds</title><link>http://MzAwMDA5NTIxNQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>安进近20亿美元囊获创新胃癌一线疗法，再鼎拥有大中华区权益</title><link>https://mp.weixin.qq.com/s/Dqzq7MfyjwwEQgTPSxwUkw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNNl1vSbCHk8F1sibDbYAFOprj5Jh59eibBDeNkiawRdhhpPNqEAfibkYXrsK7DXZXNicA70MMcbzib2vYA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>治疗胃癌的精准疗法]]></content:encoded><pubDate>Fri, 05 Mar 2021 08:04:27 +0800</pubDate></item><item><title>速递 | 一线治疗非小细胞肺癌，辉瑞第三代ALK抑制剂获FDA批准</title><link>https://mp.weixin.qq.com/s/07lvvknKCa2mUSrNN3ngJw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNNl1vSbCHk8F1sibDbYAFOpaxTibbYhlhDvSkH0bOL4FFrq0KPibmnrcTRThr9UIklMC7uTPTr4ygww/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>降低疾病进展和死亡风险72%]]></content:encoded><pubDate>Fri, 05 Mar 2021 08:04:27 +0800</pubDate></item><item><title>速递 | 50%患者血糖指标达到正常水平，礼来糖尿病创新疗法达到3期临床终点</title><link>https://mp.weixin.qq.com/s/N-z2brmzWwUxMxzqZBM6vw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNNl1vSbCHk8F1sibDbYAFOpibWua4DtVZrHGCkibibiaSHX9F55qYH8WH3Ro6qVvTMJH1B8IzgjWYdP8w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>GIP/GLP-1受体双重激动剂]]></content:encoded><pubDate>Fri, 05 Mar 2021 08:04:27 +0800</pubDate></item><item><title>连发3篇顶刊！《柳叶刀》：索马鲁肽带来2型糖尿病体重管理突破，全面改善健康</title><link>https://mp.weixin.qq.com/s/gjRyor1Np-9YKYUuiej-BA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNNl1vSbCHk8F1sibDbYAFOpIt4ZTCy2ypAHxhs5ibaeI10R5GWEHY7FetRDmeZsuPqV9KOLzibG4cOQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>超过1/4的患者减重超过15%]]></content:encoded><pubDate>Fri, 05 Mar 2021 08:04:27 +0800</pubDate></item><item><title>ASCO权威发布！2020年抗癌领域20项重要临床研究，它们有哪些亮点？</title><link>https://mp.weixin.qq.com/s/SdsDa5a4F3sKcrfk6gzkoA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNNl1vSbCHk8F1sibDbYAFOpmCqHOiaDVN8fndNWSFN7zgFHcKbo7Iolgl3y5kKpic4TBPeVdK6YHCLQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>ASCO年度抗癌进展报告]]></content:encoded><pubDate>Fri, 05 Mar 2021 08:04:27 +0800</pubDate></item><item><title>一个家庭三场癌症…他痛失独子，却给千万患者带来了希望</title><link>https://mp.weixin.qq.com/s/x06SGR_V4eLmf1Ev9Mj0Gg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gOojLqRibsalhbyiaibdtQjQqyOrzwUHeQW5IhWEynVusJknpCPCDar9OtTiaO3jGpB82IgObj52VRcicg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>开发突破性技术，提高人们生存机会]]></content:encoded><pubDate>Thu, 04 Mar 2021 08:17:26 +0800</pubDate></item><item><title>成功促进头发再生！礼来JAK抑制剂达到3期临床终点</title><link>https://mp.weixin.qq.com/s/oM0Ee9F8bnqep-W6SlIB3g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gOojLqRibsalhbyiaibdtQjQqyG9YVpIk55OvP2MUBK8qKgiapvqBvxSekxMh1G8PkNgp8MenYDt55GQg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>首个在治疗斑秃的3期临床试验中获得积极结果的JAK抑制剂]]></content:encoded><pubDate>Thu, 04 Mar 2021 08:17:26 +0800</pubDate></item><item><title>速递 | 使用两周，管用3年？糖尿病免疫疗法公布最新结果</title><link>https://mp.weixin.qq.com/s/h2LttPtdmeS2fCXhxJKcXA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNNl1vSbCHk8F1sibDbYAFOpBygEdZh4yacw1OKtBfed77VW3axn5VWCjVyCwq74aTY4BO3kDKDPwA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>今年夏天有望获得FDA批准]]></content:encoded><pubDate>Thu, 04 Mar 2021 08:17:26 +0800</pubDate></item><item><title>速递 | 影响近十分之一学龄儿童！这种疾病今天有了新药</title><link>https://mp.weixin.qq.com/s/vKXmV0GuNsSnua4BpygucA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gNNl1vSbCHk8F1sibDbYAFOptwDNul7FqqTnKMumDKjQuolicLI4y8w5F2sUWFjM2WZ89v7or2lgxzg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药明康德]]></content:encoded><pubDate>Thu, 04 Mar 2021 08:17:26 +0800</pubDate></item><item><title>穿越血脑屏障！这些递送技术有望改变疾病治疗</title><link>https://mp.weixin.qq.com/s/VoSFlfELpMrkzGWTIEsywQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/mfqJoCeoVIsMkhic51wxWG75VPEblbFGiczP6cEajtAxRmUURJXKA1icEZZZWRKeDLHkxicreP91D82MRgxIARmlyA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>有哪些递送技术可穿越血脑屏障？]]></content:encoded><pubDate>Thu, 04 Mar 2021 08:17:26 +0800</pubDate></item><item><title>效果堪比减肥手术！减重17kg，减肥疗法又一突破性结果发表JAMA</title><link>https://mp.weixin.qq.com/s/aLTZJskyXI1mUWbgx4lW4A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/EIicaxb3hLFUHVibQ1wrh9Miaj0ibGkrrFEJMS9LNWljwyJibQUJqZBHZBCt1jFuG11GUVmHInlTzRqibnLYq0I0Yexw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>每周一针，结合饮食和锻炼强化干预，治疗68周]]></content:encoded><pubDate>Thu, 04 Mar 2021 08:17:26 +0800</pubDate></item><item><title>阿斯利康新冠疫苗真实世界数据首次公布，一针就可显著降低老年人患病和住院风险</title><link>https://mp.weixin.qq.com/s/Mokkhp5s5rNMVJgfR1AO6g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gO1L7YJfaQvr5wSibmOHyHFwZiaChcP4jlRvgAluwQibZKFnwce76k13x1xorDEzIq8kIWWFhiaFaR1nA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>药明康德]]></content:encoded><pubDate>Wed, 03 Mar 2021 07:40:00 +0800</pubDate></item><item><title>跨越十年，超1万药物临床项目分析报告：临床开发成功率仅7.9%，平均历时10.5年</title><link>https://mp.weixin.qq.com/s/I8kEZ8gFPvblVXfQkIzejQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/IeJiaQ7ImT1ycrIH8xuDEw6icHogKDmLtnCRibibTeBliaiaEQPicll9Vtg1MCUXJBsev9jCBrRHfXawvl6LG1icPG8MZg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>对2011年-2020年期间的上万个临床项目成功率进行了分析]]></content:encoded><pubDate>Wed, 03 Mar 2021 07:40:00 +0800</pubDate></item><item><title>速递 | 降低疾病复发风险67%，安进双特异性抗体疗法3期临床结果发布</title><link>https://mp.weixin.qq.com/s/v0tFCb0bSfzdElp8ezRf-Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gO1L7YJfaQvr5wSibmOHyHFwsb65PZYVbvo0tRmY6KVFvMCWWzCQeoVlHReSHyBy6iaUq293quq1ic7g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>靶向CD19的双特异性T细胞接合器]]></content:encoded><pubDate>Wed, 03 Mar 2021 07:40:00 +0800</pubDate></item><item><title>速递 | 有望给人移植猪器官，杨璐菡联合创立公司获1.25亿美元助力</title><link>https://mp.weixin.qq.com/s/aQ9nJsO9-j3NFib45URT6w</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gO1L7YJfaQvr5wSibmOHyHFwibMOhNq41aBGuWqx52DoH5LVoAMW9zicYZcpibNPK19kXkgfBNOF2353g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>由麻省理工学院（MIT）的George Church教授和杨璐菡博士联合创建]]></content:encoded><pubDate>Wed, 03 Mar 2021 07:40:00 +0800</pubDate></item><item><title>怎么减肥更容易成功？科学家汇集数十项研究确认了一个好用的方法</title><link>https://mp.weixin.qq.com/s/ArUpCopvK1Z2ivf2d4jQYA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/UdvecgtVRYLYcsfsATYymOic1ma42TcLFiaNtXx2cROCq3b85YUeZqREVgmyGPneZIRxCic0sVUaz6hc8m1SLXnRw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>世间的减肥方法很多，达成减肥目标却很难]]></content:encoded><pubDate>Wed, 03 Mar 2021 07:40:00 +0800</pubDate></item><item><title>明日下午3点！临床前新药CMC的关键风险分析与应对</title><link>https://mp.weixin.qq.com/s/pwc8JW47__pJznsOf6jiNg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gO1L7YJfaQvr5wSibmOHyHFwLCIZUU0GIC1JjtynJlnn5nypaREkUNrRVxsxhfsqBb5RCqfK6ibibL2g/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CMC系列（十一）]]></content:encoded><pubDate>Wed, 03 Mar 2021 07:40:00 +0800</pubDate></item><item><title>药明康德宣布完成对OXGENE的收购，持续加强细胞和基因疗法全球服务能力 | Bilingual News</title><link>https://mp.weixin.qq.com/s/U1hME3TXGz27lD2BG7X8OQ</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gO1L7YJfaQvr5wSibmOHyHFwmOcXyslicdcRIvejicOMtHX7w6shb32ibicIEWAic4O3qZTDYEtdNGIkngg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>WuXi AppTec Completes Acquisition of OXGENE]]></content:encoded><pubDate>Tue, 02 Mar 2021 20:10:58 +0800</pubDate></item><item><title>成功靶向两大“不可成药”靶点，双特异性抗体研究再获突破！</title><link>https://mp.weixin.qq.com/s/XFsMa-doUTeJi66n_ZU1xw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gO1L7YJfaQvr5wSibmOHyHFw7efSgPskNra5qL50OH2AmwyKmF2hHNqTeZRX712UUoJTWLT1KicYTMA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>靶向p53和RAS]]></content:encoded><pubDate>Tue, 02 Mar 2021 20:10:58 +0800</pubDate></item><item><title>速递 | 约10亿美元囊获突破性头颈癌疗法，德国默克达成许可协议</title><link>https://mp.weixin.qq.com/s/L5Z0pJm9PpZEy0OGJ4purg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/FcLK21Ir4gO1L7YJfaQvr5wSibmOHyHFwYC22AA0xIzoknAHCeY797HFjq3yS1cBOuQsq4uuOup7CldxUvTiaPLA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>潜在“first-in-class”凋亡蛋白抑制剂的口服拮抗剂]]></content:encoded><pubDate>Tue, 02 Mar 2021 20:10:58 +0800</pubDate></item></channel></rss>